Product Monograph Template - Schedule D]
Attachment: Product Information: Reslizumab
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
including co-pays, co-insurance, and deductibles.*
Reslizumab (Cinqair) Approved to Treat Severe Asthma | RT
Reslizumab | New Drug Approvals
test-placeholder-02.png
Cinqair Prices, Coupons & Savings Tips - GoodRx
CINQAIR® (reslizumab) Injection – About Asthma Control
video-placeholder-01.png
CINQAIR® (reslizumab) Injection – About Asthma Control
761033Orig1s000
Cinqair (Reslizumab) 100mg/10mL Injection – Apothera
New Drug Product: Cinqair - MPR
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
Drug Analysis: Cinqair - Research and Markets
hcp.cinqair.com
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
CINQAIR - Teva Pharmaceutical Industries Limited Trademark Registration
Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients
Cinqair (reslizumab)- Asthma- by Saro Arakelians, PharmD- Episode # 123 - YouTube
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
